Literature DB >> 18927433

Integrin alpha(v)beta(3) on human endothelial cells binds von Willebrand factor strings under fluid shear stress.

Jing Huang1, Robyn Roth, John E Heuser, J Evan Sadler.   

Abstract

Acutely secreted von Willebrand factor (VWF) multimers adhere to endothelial cells, support platelet adhesion, and may induce microvascular thrombosis. Immunofluorescence microscopy of live human umbilical vein endothelial cells showed that VWF multimers rapidly formed strings several hundred micrometers long on the cell surface after stimulation with histamine. Unexpectedly, only a subset of VWF strings supported platelet binding, which depended on platelet glycoprotein Ib. Electron microscopy showed that VWF strings often consisted of bundles and networks of VWF multimers, and each string was tethered to the cell surface by a limited number of sites. Several approaches implicated P-selectin and integrin alpha(v)beta(3) in anchoring VWF strings. An RGDS peptide or a function-blocking antibody to integrin alpha(v)beta(3) reduced the number of VWF strings formed. In addition, integrin alpha(v) decorated the VWF strings by immunofluorescence microscopy. Furthermore, lentiviral transduction of shRNA against the alpha(v) subunit reduced the expression of cell-surface integrin alpha(v)beta(3) and impaired the ability of endothelial cells to retain VWF strings. Soluble P-selectin reduced the number of platelet-decorated VWF strings in the absence of Ca(2+) and Mg(2+) but had no effect in the presence of these cations. These results indicate that VWF strings bind specifically to integrin alpha(v)beta(3) on human endothelial cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927433      PMCID: PMC2644087          DOI: 10.1182/blood-2008-05-158584

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  45 in total

1.  Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.

Authors:  Jian-Ping Xiong; Thilo Stehle; Rongguang Zhang; Andrzej Joachimiak; Matthias Frech; Simon L Goodman; M Amin Arnaout
Journal:  Science       Date:  2002-03-07       Impact factor: 47.728

2.  Lentiviral and MLV based retroviral vectors for ex vivo and in vivo gene transfer.

Authors:  Armin Blesch
Journal:  Methods       Date:  2004-06       Impact factor: 3.608

3.  Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice.

Authors:  David G Motto; Anil K Chauhan; Guojing Zhu; Jonathon Homeister; Colin B Lamb; Karl C Desch; Weirui Zhang; Han-Mou Tsai; Denisa D Wagner; David Ginsburg
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

4.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

5.  Aspects of hydrodynamic shear regulating shear-induced platelet activation and self-association of von Willebrand factor in suspension.

Authors:  Harish Shankaran; Paschalis Alexandridis; Sriram Neelamegham
Journal:  Blood       Date:  2002-11-27       Impact factor: 22.113

6.  Platelets adhere to and translocate on von Willebrand factor presented by endothelium in stimulated veins.

Authors:  P André; C V Denis; J Ware; S Saffaripour; R O Hynes; Z M Ruggeri; D D Wagner
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

7.  Unique ability of integrin alpha(v)beta 3 to support tumor cell arrest under dynamic flow conditions.

Authors:  Jan Pilch; Rolf Habermann; Brunhilde Felding-Habermann
Journal:  J Biol Chem       Date:  2002-04-04       Impact factor: 5.157

8.  P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface.

Authors:  Arnoldo Padilla; Joel L Moake; Aubrey Bernardo; Chalmette Ball; Yongtao Wang; Maneesh Arya; Leticia Nolasco; Nancy Turner; Michael C Berndt; Bahman Anvari; José A López; Jing-Fei Dong
Journal:  Blood       Date:  2003-11-20       Impact factor: 22.113

9.  Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5.

Authors:  Xiao-Feng Qin; Dong Sung An; Irvin S Y Chen; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-23       Impact factor: 11.205

10.  ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions.

Authors:  Jing-fei Dong; Joel L Moake; Leticia Nolasco; Aubrey Bernardo; Wendy Arceneaux; Corie N Shrimpton; Alicia J Schade; Larry V McIntire; Kazuo Fujikawa; José A López
Journal:  Blood       Date:  2002-07-25       Impact factor: 22.113

View more
  59 in total

1.  In vitro microvessels for the study of angiogenesis and thrombosis.

Authors:  Ying Zheng; Junmei Chen; Michael Craven; Nak Won Choi; Samuel Totorica; Anthony Diaz-Santana; Pouneh Kermani; Barbara Hempstead; Claudia Fischbach-Teschl; José A López; Abraham D Stroock
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

2.  Shiga toxin B subunits induce VWF secretion by human endothelial cells and thrombotic microangiopathy in ADAMTS13-deficient mice.

Authors:  Jing Huang; David G Motto; David R Bundle; J Evan Sadler
Journal:  Blood       Date:  2010-07-19       Impact factor: 22.113

3.  Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signaling pathways.

Authors:  Fang Liu; Jing Huang; J Evan Sadler
Journal:  Blood       Date:  2011-08-03       Impact factor: 22.113

4.  Endothelial von Willebrand factor regulates angiogenesis.

Authors:  Richard D Starke; Francesco Ferraro; Koralia E Paschalaki; Nicola H Dryden; Thomas A J McKinnon; Rachel E Sutton; Elspeth M Payne; Dorian O Haskard; Alun D Hughes; Daniel F Cutler; Mike A Laffan; Anna M Randi
Journal:  Blood       Date:  2010-11-03       Impact factor: 22.113

5.  Role of CD40 and ADAMTS13 in von Willebrand factor-mediated endothelial cell-platelet-monocyte interaction.

Authors:  Miruna Popa; Sibgha Tahir; Julia Elrod; Su Hwan Kim; Florian Leuschner; Thorsten Kessler; Peter Bugert; Ulrich Pohl; Andreas H Wagner; Markus Hecker
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-23       Impact factor: 11.205

6.  Cooperation within von Willebrand factors enhances adsorption mechanism.

Authors:  Maziar Heidari; Mehrdad Mehrbod; Mohammad Reza Ejtehadi; Mohammad R K Mofrad
Journal:  J R Soc Interface       Date:  2015-08-06       Impact factor: 4.118

Review 7.  Angiodysplasia in von Willebrand Disease: Understanding the Clinical and Basic Science.

Authors:  Soundarya Selvam; Paula James
Journal:  Semin Thromb Hemost       Date:  2017-05-05       Impact factor: 4.180

8.  The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium.

Authors:  Thejaswi Kalagara; Tracy Moutsis; Yi Yang; Karin I Pappelbaum; Anne Farken; Lucia Cladder-Micus; Sabine Vidal-Y-Sy; Axel John; Alexander T Bauer; Bruno M Moerschbacher; Stefan W Schneider; Christian Gorzelanny
Journal:  Blood Adv       Date:  2018-09-25

Review 9.  Diverse activities of von Willebrand factor in traumatic brain injury and associated coagulopathy.

Authors:  Xin Xu; Rosemary Kozar; Jianning Zhang; Jing-Fei Dong
Journal:  J Thromb Haemost       Date:  2020-10-06       Impact factor: 5.824

10.  Cocaine and specific cocaine metabolites induce von Willebrand factor release from endothelial cells in a tissue-specific manner.

Authors:  William E Hobbs; Emily E Moore; Rebecca A Penkala; Douglas D Bolgiano; José A López
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-03-28       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.